MTOR and ovarian cancer: As expected, HF remarkably inhibited phosphorylation of mTOR and eIF2α in ovarian cancer CAF1 and CAF2 respectively, which in turn affected ATF4 expression in a time‐dependent manner (Figure 5H; Figure S13, Supporting Information).